Targeting the Mammalian Target of Rapamycin in Lung Cancer.
about
Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2.Amino acid profiles as potential biomarkers for pediatric cancers: a preliminary communication.Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies.Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
P2860
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
@en
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
@nl
type
label
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
@en
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
@nl
prefLabel
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
@en
Targeting the Mammalian Target of Rapamycin in Lung Cancer.
@nl
P2860
P1476
Targeting the Mammalian Target of Rapamycin in Lung Cancer
@en
P2093
Jesse Roman
P2860
P304
P356
10.1016/J.AMJMS.2016.08.014
P407
P577
2016-08-21T00:00:00Z